13F HOLDINGS REPORT
BIOIMPACT CAPITAL LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0000950123-23-007806
Total Value
$496.6M
Positions
34
Other Managers
0
Confidential Omitted
No
Holdings (34)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Cullinan Oncology, Inc. | CGEM | 7,648,268 | $82.3M | 16.57% |
| 2 | Iveric Bio Inc | 46583P102 | 1,214,662 | $47.8M | 9.62% |
| 3 | Chinook Therapeutics, Inc. | 16961L106 | 1,003,406 | $38.6M | 7.76% |
| 4 | Geron Corporation | GERN | 9,191,290 | $29.5M | 5.94% |
| 5 | Reata Pharmaceuticals, Inc. | 75615P103 | 234,478 | $23.9M | 4.81% |
| 6 | iTeos Therapeutics, Inc. | 46565G104 | 1,745,943 | $23.1M | 4.65% |
| 7 | Intellia Therapeutics, Inc. | NTLA | 544,639 | $22.2M | 4.47% |
| 8 | Iovance Biotherapeutics Inc | IOVA | 2,950,118 | $20.8M | 4.18% |
| 9 | Repare Therapeutics, Inc. | 760273102 | 1,639,849 | $17.3M | 3.49% |
| 10 | Relay Therapeutics Inc. | RLAY | 1,354,368 | $17.0M | 3.43% |
| 11 | Verve Therapeutics, Inc | 92539P101 | 857,940 | $16.1M | 3.24% |
| 12 | Moonlake Immunotherapeutics | MLTX | 295,111 | $15.1M | 3.03% |
| 13 | REGENXBIO Inc. | RGNX | 656,718 | $13.1M | 2.64% |
| 14 | Karuna Therapeutics Inc | 48576A100 | 53,399 | $11.6M | 2.33% |
| 15 | Insmed Incorporated | INSM | 529,743 | $11.2M | 2.25% |
| 16 | Xeris Biopharma Holdings Inc | XERS | 3,974,999 | $10.4M | 2.10% |
| 17 | Madrigal Pharmaceuticals inc | MDGL | 38,011 | $8.8M | 1.77% |
| 18 | Crinetics Pharmaceuticals Inc. | CRNX | 479,053 | $8.6M | 1.74% |
| 19 | Travere Therapeutics Inc. | TVTX | 552,846 | $8.5M | 1.71% |
| 20 | Revolution Medicines, Inc. | RVMDW | 273,408 | $7.3M | 1.47% |
| 21 | Werewolf Therapeutics, Inc. | HOWL | 2,388,011 | $7.3M | 1.47% |
| 22 | Kalvista Pharmaceuticals Inc | KALV | 761,538 | $6.9M | 1.38% |
| 23 | Axsome Therapeutics, Inc. | AXSM | 93,586 | $6.7M | 1.35% |
| 24 | Amicus Therapeutics Inc. | FOLD | 516,139 | $6.5M | 1.31% |
| 25 | Avadel Pharmaceuticals PLC | 05337M104 | 384,990 | $6.3M | 1.28% |
| 26 | Viridian Therapeutics Inc | VRDN | 255,323 | $6.1M | 1.22% |
| 27 | Edgewise Therapeutics Inc | EWTX | 712,798 | $5.5M | 1.11% |
| 28 | Adaptimmune Therapeutics plc | ADTI | 5,095,912 | $4.7M | 0.95% |
| 29 | Olema Pharmaceuticals, Inc. | OLMA | 462,500 | $4.2M | 0.84% |
| 30 | Phathom Pharmaceuticals inc | PHAT | 282,332 | $4.0M | 0.81% |
| 31 | Harpoon Therapeutics, Inc. | 41358P106 | 3,196,707 | $2.3M | 0.46% |
| 32 | Inozyme Pharma Inc. | 45790W108 | 326,921 | $1.8M | 0.37% |
| 33 | Ventyx Biosciences Inc | 92332V107 | 31,747 | $1.0M | 0.21% |
| 34 | Oncorus, Inc. | 68236R103 | 2,377,031 | $96,270 | 0.02% |